Rynaxypyr
-
FMC Posts $2.2 Billion Loss, Launches Strategic Review Including Possible Sale
After posting a loss of more than $2 billion in 2025, FMC Corp., based in Philadelphia’s University City, is considering a potential sale, writes Michael…
Founding Partners
Advertisement
Affiliate Partners
